🇺🇸 FDA

Company profile · Sponsor

Foghorn

Foghorn Therapeutics

FHTX · NYSE pharma CAMBRIDGE, MA, USA
Pipeline
5
Drugs
0
Patents
8

Quick answer

Foghorn (FHTX) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker FHTX
Exchange NYSE
Company type pharma
Headquarters CAMBRIDGE, MA, USA
SEC CIK 0001822462

Pipeline (5)

Search pipeline →

  1. FHD-286

    Foghorn

    Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  2. Decitabine

    Foghorn

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  3. FHD-286

    Foghorn

    Advanced Hematologic Malignancy

    phase 1 small molecule active

    1 trial

  4. FHD-286

    Foghorn

    Metastatic Uveal Melanoma

    phase 1 small molecule terminated

    1 trial

  5. FHD-609

    Foghorn

    Advanced Synovial Sarcoma

    phase 1 small molecule terminated

    1 trial

Patents (8)

Search patents →

  1. US 12391686

    Compounds and uses thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12384776

    Compounds and uses thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12383555

    Methods of treating cancers

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12383560

    Compounds and uses thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12351579

    Compounds and uses thereof

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12139487

    Compounds and uses thereof

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11851445

    Compounds and uses thereof

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11787800

    BRD9 degraders and uses thereof

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Foghorn?

Foghorn (FHTX) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Foghorn sponsor?

We track 5 ClinicalTrials.gov-linked programs for Foghorn, including FHD-286 and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Foghorn company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.